Episode 1: Episode 1: S.6 Ep.1 Cancer Prevention with Resistant Starch in Lynch (CAPP2 Trial)

This episode is hosted by Swati G. Patel, M.D., MS and features Sir John Burn, M.D., MBBS, BMedSci, a professor of Clinical Genetics at Newcastle University and senior leader in England's National Health Service.  Together they discuss the  10 year follow-up results of the seminal Cancer Prevention Programme (CAPP2) trial described in the Cancer Prevention Research article titled “Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo-Controlled Trial: Planned 10-Year Follow-up” which can be found here. Read our blog post Does starch prevent cancer in patients with lynch syndrome by a mechanism that might be applicable to the general population here.